로딩 중…
지수 로딩 중…
NEUROPHET Inc.
380550· KOSDAQ· Health Care· Health Care Equipment & Services
₩11,490-7.86%
2026-06-19
Price Chart
NEUROPHET Inc.
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 140.16B KRW |
| Revenue | 2.62B KRW |
| Net Income | -9.68B KRW |
| Total Assets | 26.88B KRW |
| Net Assets | 19.45B KRW |
| Value | |
| P/B | 7.21x |
| P/S | 53.60x |
| FCF Yield | -10.77% |
| Profitability | |
| ROE | -49.79% |
| ROA | -36.02% |
| Op. Margin | -632.84% |
| Financial Health | |
| Debt Ratio | 38.21% |
| Total Debt | 4.80B KRW |
| FCF | -15.10B KRW |
| Cash | 4.10B KRW |
| Current Ratio | 3.61x |
| Performance | |
| 1M Return | -27.37% |
| From 52W High | -68.69% |
| 1Y MDD | -69.02% |
| Trading | |
| Volume | 164,548 shares |
| Foreign Own. | 0.62% |
| Per Share | |
| EPS | -2,107 KRW |
| BPS | 1,571 KRW |
Company Info
Neurophit was established in 2016 as a specialized AI solution company for brain diseases and is scheduled to be listed on KOSDAQ in 2025. The company develops AI technology-based brain image analysis software and therapeutic medical devices, providing full-cycle brain disease medical solutions from diagnosis to treatment. Neurophit possesses AQUA for degenerative brain disease diagnosis support, SCALE PET for PET image analysis, and AQUA AD for Alzheimer's solutions, while continuously conducting R&D in various brain disease fields such as depression treatment and brain MRI. Neurophit is headquartered in Gangnam-gu, Seoul.